Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2018 Apr;27(2):349-365.
doi: 10.1016/j.soc.2017.11.008.

Clinical Trials and Progress in Metastatic Colon Cancer

Kabir Mody  1 , Tanios Bekaii-Saab  2
Affiliations
Review

Clinical Trials and Progress in Metastatic Colon Cancer

Kabir Mody et al. Surg Oncol Clin N Am. 2018 Apr.

Abstract

Colorectal cancer (CRC) is a leading cause of cancer-related deaths worldwide but associated mortality has declined in recent decades. Genomic profiling of the disease has resulted in the definition of subsets of patients-for example, KRAS, NRAS, or BRAF mutated; Her2 amplified; and mismatch repair deficient-which has enabled personalization of therapeutic decision making. These subsets are guiding drug development and combination therapy approaches using both targeted therapies and immunotherapies. Further refinement based on molecular discoveries and the emergence of newer technologies to enable new discoveries allow for great optimism for the future on behalf of patients with colon cancer.

Keywords: BRAF; Clinical trials; Colorectal cancer; Her2; Immunotherapy; KRAS.

PubMed Disclaimer